...Vectura's Innovata Ltd. subsidiary granted Broadvector rights to IP covering a prodrug therapy for hip implant...

...$78.00 56% $3.7B in cash 11/9/06 Tanox Genentech $13.64 $20.00 47% $919M in cash 11/17/06 Innovata...

...Jan. 17, the last trading day before the deal closed (see BioCentury, Nov. 20, 2006). Innovata plc...

...BioMedica 11/16/05 Placing and open £27.2 ($47.4) Ark Therapeutics 4/27/06 Placing and open £27.1 ($48.3) Innovata...

...a 116p target. Last month, the drug delivery company said it will acquire pulmonary play Innovata...

...Piper Jaffray advised VEC on the deal, which is expected to close by Jan. 16. Innovata plc...

...Vectura (LSE:VEC) will acquire pulmonary company Innovata (LSE:IOV) for 26p per share, or L130.9 million ($250.1...

...dermatology play for $17.50 per share, or about $640M in cash (see "Connetics Chronicles," A21). Innovata...

...of Baxter International Inc. (BAX, Deerfield, Ill.). Adept has been marketed in Europe since 2000. Innovata plc...

...proposals for post-approval safety monitoring. IOV plans to submit this information as quickly as possible. Innovata plc...